Trial intelligence / Profile preview

Tapinarof cream in plaque psoriasis

NCT03983980Phase 3Completed

Sponsor
Organon & Co.
Start
Jun 2019
Primary completion
May 2020
Modality
Small Molecules
Countries
2
01

Overview

A Phase 3 trial of tapinarof in plaque psoriasis, sponsored by Organon & Co.. Started Jun 2019; status: completed.

02

Drugs

tapinarof
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on NCT03983980.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03983980.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call